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Triclosan  is  widely  used  as  an  antimicrobial  agent  and  preservative  that  has  been  hypothesized  to play  a
role  in asthma  and  allergic  disease.  The  limited  body  of  literature  regarding  the  allergenicity  of  triclosan
has  not  evaluated  prenatal  exposure  and  subsequent  potential  effects  on  the  developing  immune  system.
The objective  of  the  present  study  was  to determine  the  association  between  prenatal  urinary  triclosan
concentrations  and  cord  blood  immune  system  biomarker  concentrations.  Umbilical  cord  blood  samples
were obtained  from  the  Maternal-Infant  Research  on  Environmental  Chemicals  (MIREC)  Biobank  andregnancy
irth cohort
mmune system development
were  tested  for  three  immune  system  biomarkers:  immunoglobulin  E (IgE),  thymic  stromal  lymphopoi-
etin  (TSLP),  and interleukin-33  (IL-33).  Triclosan  concentrations  were  measured  in urine  at  6–13 weeks
gestation.  No statistically  signiﬁcant  associations  were  observed  between  prenatal  triclosan  concentra-
tions  and  elevated  concentrations  of  any  immune  system  biomarker  (n = 1219  participants).  Longitudinal
studies  are  necessary  to  determine  how  the  observed  ﬁndings  at birth  translate  into  childhood.
© 2016  The  Authors.  Published  by  Elsevier  GmbH.  This  is  an  open  access  article  under  the  CC. Introduction
Triclosan is widely used as an antimicrobial agent and preserva-
ive. Common sources of exposure to triclosan include cosmetics,
ntibacterial soaps, and other household cleaning products (Health
anada and Environment Canada, 2012). Triclosan has been
ypothesized to play a role in asthma and allergic disease
Anderson et al., 2013). The potential association between triclosan
xposure and increased risk of allergic disease is consistent with the
ypothesis that reduced microorganism exposure, due, in part, to
he ubiquity of antibacterial soaps containing triclosan, may  exac-
rbate susceptibility to childhood allergic disease (Calafat et al.,
008; Health Canada, 2015). Established risk factors, such as genet-
cs and environmental tobacco smoke exposure, are likely involved
n less than one half of childhood allergic disease cases (Backman
t al., 2014; Cookson et al., 2011) and exposure to environmen-
al contaminants has also been hypothesized to be responsible for
ome portion of these cases (Ho, 2010).
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438-4639/© 2016 The Authors. Published by Elsevier GmbH. This is an open access artic
.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Authors of studies using US NHANES data (National Health and
Nutrition Examination Survey) reported that urinary triclosan con-
centrations were positively associated with allergic sensitization
in children between 6 and 18 years (Clayton et al., 2011; Savage
et al., 2012). Parental-reported antimicrobial exposure has also
been associated with a higher likelihood of wheezing and aller-
gic rhinitis symptoms in children under the age of 13 (Hong et al.,
2014). Urinary triclosan concentrations have been similarly associ-
ated with increased odds of allergic sensitization among Norwegian
children (Bertelsen et al., 2013). These studies have not focused
on exposure during pregnancy and subsequent effects on offspring
immune system development.
Considering that the fetal time period is a critical window
of immune system development and enhanced susceptibility to
potential adverse effects of environmental exposures, we  endeav-
ored to determine the association between prenatal triclosan
exposure and concentrations of cord blood immune system
biomarkers. The biomarkers measured in this study included
immunoglobulin E (IgE), Interleukin-33 (IL-33) and thymic stro-
mal  lymphopoietin (TSLP). IgE has been previously examined as a
biomarker of immune system susceptibility to prenatal environ-
mental contaminant exposures (Herr et al., 2011). IL-33 and TSLP
have been recently recognized as being integral to the mechanisms
underlying allergy (Bartemes and Kita, 2012), atopic dermati-
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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Table  1
Adjusteda odds ratios (95% CI) of elevated cord blood immune system biomarkers and quartiles of urinary triclosan.
Triclosan (g/L) IgE IL-33 TSLP IL-33/TSLP
<2.30 1.0 1.0 1.0 1.0
2.30–<8.90 1.50 (0.95–2.38) 1.41 (0.92–2.17) 1.24 (0.82–1.89) 1.35 (0.85–2.15)
8.90–<77.09 1.29 (0.82–2.06) 1.21 (0.78–1.87) 1.13 (0.74–1.71) 1.21 (0.76–1.92)
≥77.09 1.03 (0.63–1.68) 1.32 (0.85–2.05) 1.08 (0.70–1.66) 1.17 (0.72–1.89)
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is (Brandt and Sivaprasad, 2011), and asthma (Gauvreau et al.,
014). Further, a recent experimental study reported that triclosan
nduced TSLP and IL-33 expression in human skin (Marshall et al.,
015), suggesting that triclosan plays a role in triggering allergy
esponse.
. Material and methods
Data and biospecimens were obtained from the Maternal-Infant
esearch on Environmental Chemicals (MIREC) Study, a trans-
anada cohort study of 2001 pregnant women from ten Canadian
ities recruited between 2008 and 2011 (Arbuckle et al., 2013).
he study population for the MIREC Study and the sub-cohort
or the present analysis have been described previously (Arbuckle
t al., 2013; Ashley-Martin et al., 2015). Umbilical cord blood sam-
les that were determined to be contaminated with maternal
lood based on an elevated immunoglobulin A (IgA) concentra-
ion (≥10 g/mL) were excluded from the analysis (Ownby et al.,
996). As pre-term and multiple birth infants had lower cord blood
oncentrations of the immune system biomarkers and may  have a
iffering allergic disease risk proﬁle (Algert et al., 2011; Been et al.,
014), these subjects were excluded from this study. This study
eceived ethical approval from Health Canada, St. Justine’s Hospi-
al (Montreal, QC) and the IWK  Health Centre (Halifax, NS) and all
articipants provided consent.
Immune system biomarkers were measured in the plasma of
mbilical cord blood samples (details in Ashley-Martin et al., 2015).
SLP concentrations were determined using a commercial antibody
it (Biolegend, San Diego, CA, USA). IL-33 concentrations were ana-
yzed using antibodies from an R & D systems duoset (Minneapolis,
N,  USA). ELISA kits (EBioscience, San Diego, CA, USA) were also
sed to assess both total IgE and IgA concentrations.
Urinary concentrations of free and conjugated forms of tri-
losan were measured in the ﬁrst trimester (6–13 weeks) in MIREC
tudy participants. Details regarding triclosan measurement meth-
ds and descriptive results are presented elsewhere (Arbuckle et al.,
015). In this study, triclosan concentrations are reported as total
riclosan and represent the sum of free and conjugated forms. The
imit of detection (LOD) for total triclosan was 0.12 g/L, which is
he more conservative LOD of the two triclosan components. Values
elow the LOD are reported as machine readings.
The immune system biomarkers were dichotomized because
f the high percentage of samples that were below the LOD.
 composite variable was developed to identify samples with
levated concentrations of both TSLP and IL-33 (IL-33/TSLP) as
hese cytokines are highly correlated (Spearman correlation coef-
cient (rs) = 0.8). Because there are no pre-existing thresholds
or TSLP and IL-33, they were categorized at the 80th percentile
TSLP = 554 pg/mL; IL-33 = 879 pg/mL) to allow for a sufﬁcient sam-
le size for comparisons. Elevated concentrations of the composite
L-33/TSLP variable were deﬁned as those samples that had ele-
ated concentrations (≥80% ile) of both TSLP and IL-33. The cut-off
ercentile for IgE was deﬁned at 1.2 ng/mL (0.5 kU/L), a cut-off point
reviously used in studies of cord blood IgE (Sadeghnejad et al.,
004).We performed logistic regression to calculate the odds of
elevated biomarker concentrations according to quartiles of tri-
closan concentrations. Logistic regression models were adjusted for
maternal age and household income as these variables are poten-
tial predictors of both urinary triclosan concentrations (Calafat
et al., 2008) and the cord blood biomarkers measured in this study
(Ashley-Martin et al., 2015). Speciﬁc gravity was also included as a
covariate in the model to account for urinary dilution heterogene-
ity (Arbuckle et al., 2015). We  evaluated the relationship between
log-transformed triclosan as a continuous variable and the binary
immune system biomarkers using restricted cubic spline curves.
Effect modiﬁcation by sex was  also evaluated by examining the
signiﬁcance of the sex*triclosan product term.
3. Results
For a total of 1219 participants, both cord blood samples and
triclosan data were available and these data were included in the
present analysis. As previously reported, the majority of partici-
pants had a normal pre-pregnancy BMI, never smoked, were over
30 years of age, and had a household income greater than $50,000
(Ashley-Martin et al., 2015). Median speciﬁc gravity-adjusted tri-
closan concentrations were 9.52 g/L with an interquartile range
of 10.24 g/L. Nearly all participants (99.4%) had triclosan values
above the LOD (>0.12 g/L).
We observed positive associations between triclosan and each
biomarker but none of these associations reached statistical sig-
niﬁcance. The magnitude of the effect was  greatest in the second
quartile of exposure for each biomarker; for example, compared
to women  with triclosan concentrations below 2.30 g/L, women
with concentrations in the second quartile (2.30 to <8.90 g/L) had
a 50% increase in odds of high IgE cord blood levels (OR = 1.50; 95%
CI:0.95,2.38) (Table 1). The magnitude of this effect was  attenuated
in the third and fourth quartiles. There were no signiﬁcant associa-
tions in the spline analysis of log transformed triclosan modeled as
a continuous variable (data not shown). No effect modiﬁcation by
sex was observed (all p-values for the product terms were >0.1).
4. Discussion
We observed neither statistically signiﬁcant associations nor
dose-response relations between prenatal triclosan exposure and
cord blood levels of IgE, TSLP or IL-33, although the direction of
effect was  positive. It is possible that the lack of statistical signif-
icance reﬂects (1) a true lack of effect, (2) residual confounding
or (3) limited study power to observe the small effect sizes we
detected. Direct comparison with previous epidemiological liter-
ature is not straightforward due to differences in study design and
population. Authors of cross-sectional studies have reported that
triclosan exposure is associated with certain measures of allergic
sensitization or allergies in children 6–18 years of age (Clayton
et al., 2011; Savage et al., 2012). Median concentrations in the
MIREC Study (8.90 g/L) are comparable to those reported among
females in NHANES (8.5 g/L) (Calafat et al., 2008), suggesting that
the differences in results are not due to lower exposures in MIREC.
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Recent experimental evidence suggests that local triclosan
xposure can induce TSLP and IL-33 activity in human skin
Marshall et al., 2015). Results from a mouse model suggest that
riclosan may  exacerbate allergic responses in the presence of
o-occurring allergenic exposures, such as ovalbumin, but not in
bsence of these co-exposures (Anderson et al., 2013). It is possible,
herefore, that triclosan may  enhance the effects of co-occurring
llergens. To our knowledge, there has not been an animal model
hat has determined the relation between maternal-fetal triclosan
ransfer and resulting immune response; therefore, it is not pos-
ible to know whether triclosan exposure would elicit a maternal
mmune response that, in turn, inﬂuences fetal immune responses
r whether offspring are inﬂuenced by the direct effect of tri-
losan that has crossed the placenta. The limited epidemiological
iterature of maternal-fetal triclosan exposure has reported a poor
orrelation between maternal urinary triclosan and cord blood
lasma concentrations (Pycke et al., 2014); however, animal studies
ave demonstrated that maternal triclosan exposure does inﬂuence
ffspring outcomes such as thyroid levels (Paul et al., 2010).
The generalizability of the ﬁndings is limited by the fact that the
IREC cohort is largely Caucasian with higher income and educa-
ion levels compared to the overall Canadian population of women
n this age group. Our ﬁndings are limited by the use of a single
easurement of triclosan during the ﬁrst trimester. Triclosan is
apidly eliminated with an estimated half-life in plasma of 21 h
Sandborgh-Englund et al., 2006). A Canadian study of four prena-
al and one postpartum serial triclosan measurements reported an
ntraclass correlation coefﬁcient (ICC) of 0.50 over the entire study
eriod (Weiss et al., 2015). A study of six serial urinary triclosan
easurements in children over the course of six months reported
n ICC of 0.4(Teitelbaum et al., 2008). These values imply that ﬁrst
rimester triclosan concentrations may  be reﬂective of exposure
hroughout pregnancy, though serial measurements would be nec-
ssary to conﬁrm such reproducibility. We  explored the possibility
f selection bias in the participants of this study. Since 1363 women
rom the MIREC cohort did not provide a cord blood sample, we
ompared the distribution of factors between women who  did,
nd did not, provide a cord blood sample and found similarities
etween these two groups. Therefore, we do not think our results
re compromised by selection bias. The lack of clinical outcomes in
hildren is another limitation. Given, the lack of literature regarding
orrelation between TSLP and IL-33 at birth and in childhood, we
annot predict the extent of allergic disease among children with
igh cord blood cytokine levels; however, our study beneﬁts from
he comprehensive nature of the MIREC data. Further longitudinal
tudies are necessary to determine how the observed ﬁndings at
irth translate into childhood.
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